In summary, these data indicate that DIRAS2 inhibits CRC cells' proliferation through NF-κB signaling pathways and is degraded by PSMD2 in a proteasome-mediated way (Fig. 7E). This evidence concerns the gene DIRAS2 and colorectal carcinoma.